drugset / Trial / NCT01771471

A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo

NCT01771471 ↗

Phase 2 Terminated 44 enrolled ISTO Technologies, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a clinical study to collect safety and preliminary efficiency information on the use of NuQu chondrocytes (cartilage cells) delivered to the center of a lumbar spinal disc to treat low back pain.

Timeline

Start
2012-11
Primary completion
2020-09
Completion
2020-09

Outcome

Outcome not reported

Stopped (Business): “Change in clinical strategy”

Drugs

EvaluationDrugModalityDoseRoute
Subject NuQu Cell therapy — Other